Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

309
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
309
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

691
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
691
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

75
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
75
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

467
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
467
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

429
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
429
Causality in Epidemiology01:21

Causality in Epidemiology

1.9K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice.

BMJ oncology·2026
Same author

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Bayesian Network Analysis of Intervention-Induced Physical Activity Behavior Change: Comparative Modeling Study Across Age, Education, and Activity Impairment Subgroups.

Online journal of public health informatics·2025
Same author

Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Trial-Based Economic Evaluation.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025
Same author

Federated causal discovery with missing data in a multicentric study on endometrial cancer.

Journal of biomedical informatics·2025
Same author

Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard Dosing.

Clinical pharmacokinetics·2025

Related Experiment Video

Updated: Mar 21, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.3K

Understanding disease processes by partitioned dynamic Bayesian networks.

Marcos L P Bueno1, Arjen Hommersom2, Peter J F Lucas3

  • 1Institute for Computing and Information Sciences, Radboud University Nijmegen, The Netherlands.

Journal of Biomedical Informatics
|May 17, 2016
PubMed
Summary

This study introduces partitioned dynamic Bayesian networks to model time-varying diseases, overcoming limitations of traditional homogeneous models. The new approach accurately captures disease progression dynamics, offering better clinical insights.

Keywords:
Dynamic Bayesian networksHeuristic algorithmMultivariate time seriesNon-homogeneous stochastic processesProbabilistic graphical modelsPsychotic depression

More Related Videos

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.5K

Related Experiment Videos

Last Updated: Mar 21, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.3K
Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.5K

Area of Science:

  • Computational Biology
  • Medical Informatics
  • Statistical Modeling

Background:

  • Clinical data often exhibits temporal changes due to interventions, yet time-homogeneous models like dynamic Bayesian networks fail to capture these dynamics.
  • Existing models lose crucial pathophysiological process specificities when applied to evolving clinical conditions.

Purpose of the Study:

  • To introduce Partitioned Dynamic Bayesian Networks (PDBNs) for modeling time-varying clinical data and capturing distribution regime changes.
  • To develop a heuristic algorithm for learning non-homogeneous models that balance specificity and simplicity.

Main Methods:

  • Proposed Partitioned Dynamic Bayesian Networks (PDBNs) for representing time non-homogeneity.
  • Developed a heuristic algorithm for learning PDBNs, prioritizing model simplicity.
  • Conducted extensive simulation experiments to evaluate the algorithm's performance.

Main Results:

  • The heuristic algorithm successfully constructed models that accurately reflect underlying data-generating processes, whether homogeneous or non-homogeneous.
  • Simulated experiments demonstrated good fit and statistical accuracy of the learned models.
  • The approach effectively captured distribution regime changes inherent in clinical data.

Conclusions:

  • Partitioned Dynamic Bayesian Networks offer an intuitive and theoretically sound method for modeling time-varying pathophysiological processes.
  • The developed heuristic algorithm provides a practical solution for learning complex, non-homogeneous models from clinical data.
  • Application to psychotic depression yielded clinically relevant insights into the disorder's dynamics.